CherylRosaleeKoscikMD

PubMed

• Targeted deletion of fgl2 leads to impaired regulatory T cell activity and development of autoimmune glomerulonephritis.
  Shalev, I., Liu, H., Koscik, C., Bartczak, A., Javadi, M., Wong, K. M., Maknojia, A., He, W., Liu, M. F., Diao, J., Winter, E., Manuel, J., McCarthy, D., Cattral, M., ...> ;J Immunol. 2008 Jan 1
• Fgl2 deficiency causes neonatal death and cardiac dysfunction during embryonic and postnatal development in mice.
  Mu, J., Qu, D., Bartczak, A., Phillips, M. J., Manuel, J., He, W., Koscik, C., Mendicino, M., Zhang, L., Clark, D. A., Grant, D. R., Backx, P. H., Levy, G. A., Adamson...> ;Physiol Genomics. 2007 Sep 19
• Targeted delivery of ribavirin improves outcome of murine viral fulminant hepatitis via enhanced anti-viral activity.
  Levy, G. A., Adamson, G., Phillips, M. J., Scrocchi, L. A., Fung, L., Biessels, P., Ng, N. F., Ghanekar, A., Rowe, A., Ma, M. X., Levy, A., Koscik, C., He, W., Gorczyn...> ;Hepatology. 2006 Mar
• Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts.
  Mendicino, M., Liu, M., Ghanekar, A., He, W., Koscik, C., Shalev, I., Javadi, M., Turnbull, J., Chen, W., Fung, L., Sakamoto, S., Marsden, P., Waddell, T. K., Phillips...> ;Circulation. 2005 Jul 12
• Role of fibrinogen-like protein 2 prothrombinase/fibroleukin in experimental and human allograft rejection.
  Ning, Q., Sun, Y., Han, M., Zhang, L., Zhu, C., Zhang, W., Guo, H., Li, J., Yan, W., Gong, F., Chen, Z., He, W., Koscik, C., Smith, R., Gorczynski, R., Levy, G., Luo, X.> ;J Immunol. 2005 Jun 1
• Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of Notch signaling.
  Hitoshi, S., Seaberg, R. M., Koscik, C., Alexson, T., Kusunoki, S., Kanazawa, I., Tsuji, S., van der Kooy, D.> ;Genes Dev. 2004 Aug 1
• Join now to see all